179 related articles for article (PubMed ID: 12350235)
1. Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels.
Ferrero R; Torres M
BMC Biochem; 2002 Sep; 3():26. PubMed ID: 12350235
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells.
Liu H; Force T; Bloch KD
J Biol Chem; 1997 Feb; 272(9):6038-43. PubMed ID: 9038227
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells.
Browner NC; Dey NB; Bloch KD; Lincoln TM
J Biol Chem; 2004 Nov; 279(45):46631-6. PubMed ID: 15337747
[TBL] [Abstract][Full Text] [Related]
5. Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide.
Perkins WJ; Taniguchi M; Warner DO; Chini EN; Jones KA
Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L84-95. PubMed ID: 17384083
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation.
Ferrero R; Rodríguez-Pascual F; Miras-Portugal MT; Torres M
J Neurochem; 2000 Nov; 75(5):2029-39. PubMed ID: 11032892
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
9. Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs.
Gao Y; Dhanakoti S; Trevino EM; Wang X; Sander FC; Portugal AD; Raj JU
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L786-92. PubMed ID: 14660486
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase.
Kelly LK; Wedgwood S; Steinhorn RH; Black SM
Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L984-91. PubMed ID: 14695117
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells.
Browner NC; Sellak H; Lincoln TM
Am J Physiol Cell Physiol; 2004 Jul; 287(1):C88-96. PubMed ID: 14985234
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol modifies nitric oxide-sensitive guanylyl cyclase expression and down-regulates its activity in rat anterior pituitary gland.
Cabilla JP; Díaz Mdel C; Machiavelli LI; Poliandri AH; Quinteros FA; Lasaga M; Duvilanski BH
Endocrinology; 2006 Sep; 147(9):4311-8. PubMed ID: 16740976
[TBL] [Abstract][Full Text] [Related]
13. C-type natriuretic peptide decreases soluble guanylate cyclase levels by activating the proteasome pathway.
de Frutos S; Saura M; Rivero-Vilches FJ; Rodriguez-Puyol D; Rodriguez-Puyol M
Biochim Biophys Acta; 2003 Dec; 1643(1-3):105-12. PubMed ID: 14654233
[TBL] [Abstract][Full Text] [Related]
14. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
Takata M; Filippov G; Liu H; Ichinose F; Janssens S; Bloch DB; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L272-8. PubMed ID: 11159006
[TBL] [Abstract][Full Text] [Related]
15. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
[TBL] [Abstract][Full Text] [Related]
17. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.
Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
Hanke CJ; Drewett JG; Myers CR; Campbell WB
Endocrinology; 1998 Oct; 139(10):4053-60. PubMed ID: 9751482
[TBL] [Abstract][Full Text] [Related]
19. Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.
Perkins WJ; Kost S; Danielson M
Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L666-73. PubMed ID: 19181745
[TBL] [Abstract][Full Text] [Related]
20. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells.
Schwarz PM; Rodriguez-Pascual F; Koesling D; Torres M; Förstermann U
Neuroscience; 1998 Jan; 82(1):255-65. PubMed ID: 9483518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
